📋 About: BDA is an Australian medicinal cannabis, Cannabidiol (CBD) and hemp healthcare company that delivers premium, proven and trusted products for both the consumer and medicinal markets.
🌏 Macro Theme: The past six months has seen a large global regulatory shift with regards to cannabis classification. In Australia, the Therapeutic Goods Administration (TGA) announced a decision to down schedule CBD products to Schedule 3 (Pharmacist Only) medicines.
Additionally, a decision from the United Nations Commission on Narcotic Drugs accepted a recommendation from the World Health Organisation to remove cannabis and its derivatives from Schedule IV of the Single Convention on Narcotic Drugs.
The US House of Representatives also passed the Marijuana Opportunity Reinvestment and Expungement (“MORE”) Act to decriminalise cannabis at a national level. The bill aims to remove cannabis from the US controlled substance act, while recognising the therapeutic benefits of the drug.